Status:
COMPLETED
Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery
Lead Sponsor:
Benha University
Conditions:
Prevention of Postoperative Ileus
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
Giving women one day before and immediately after cesarean section a mouthly dissolving mosapride tablets 2every every 8 hours for maximum of 5 days ,or getting recovered gastrointestinal functions An...
Detailed Description
Uncomplicated post cesarean women one day before and immediately after elective cesarean receive 2 mouthly dissolving mosapride tablets every 8 hours maximum for 5 days and clinical care giver follow ...
Eligibility Criteria
Inclusion
- all women undergoing elective cesarean section
Exclusion
- prior abdominal surgery, abdominal adhesion, chronic constipation, allergy to mosapride
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2018
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03477266
Start Date
April 1 2018
End Date
August 1 2018
Last Update
August 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ashraf nassif Elmantwe
Banhā, Elqalopia, Egypt